Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Expert Opinion / Cases · March 09, 2023

Managing 34-Year-Old Female With a History of Gestational Diabetes

Written by
Jacqueline A. Seiglie MD, MSc

 

Discuss This item Follow

No comments yet, be the first to start the discussion!

  • Vishal Chopra

    Mar 10, 2023

    Sglt 2 inhibitors will be appropriate choice for this patient as will take care of weight as well as progression of Nephropathy

  • Annamaria Noszek

    Mar 10, 2023

    a, 

  • Otton Souza

    Mar 11, 2023

    GLP 1 is more apropriated.

  • Mehwish Saeed

    Sep 23, 2023

    SGLT 2 inhibitor is appropriate,given the  obesity and albuminuria... and preferable  over GLP1 agonists due to history  of pancreatic  in this patient

  • Mehwish Saeed

    Dec 27, 2023

    GLP 1a, since it will cause more significant  weight loss as compared to SGLT2i... renal benefit is with both. As for pancreatis... likely risk lower than benefit since post cholecystectomy  status.

  • Visala Nanduri

    Jan 27, 2024

    SGLT2 inhibitors

  • Apr 21, 2024

    Pending Moderator approval.
    Delete

Further Reading